Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
Thanikan Sukaram; Soe Thiha Maung; Yuda Chongpison; Tassanan Jaihan; Chonlada Phathong; Roongruedee Chaiteerakij;
10.1016/j.aohep.2024.101753
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
Shi-En Chong; Felicia Chang; Kee-Huat Chuah; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva; Wah-Kheong Chan;
Ann Hepatol. 2023;28:
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah; Cheng Han Ng; Kai En Chan; Clarissa Elysia Fu; Wen Hui Lim; Darren Jun Hao Tan; Benjamin Nah; Gwyneth Kong; Jieling Xiao; Jie Ning Yong; Bryan Tan; Nicholas Syn; Jiong-Wei Wang; Nilofer Sayed; Eunice Tan; Nicholas WS Chew; Yock Young Dan; Mohammad Shadab Siddiqui; Arun J. Sanyal; Mazen Noureddin;
Ann Hepatol. 2023;28: